ESMOLOL HYDROCHLORIDE- esmolol hydrochloride injection

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

ESMOLOL HYDROCHLORIDE (UNII: V05260LC8D) (ESMOLOL - UNII:MDY902UXSR)

Available from:

Cardinal Health

INN (International Name):

ESMOLOL HYDROCHLORIDE

Composition:

ESMOLOL HYDROCHLORIDE 10 mg in 1 mL

Administration route:

INTRAVENOUS

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Esmolol hydrochloride is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Esmolol hydrochloride is also indicated in noncompensatory sinus tachycardia where, in the physician’s judgment, the rapid heart rate requires specific intervention. Esmolol hydrochloride is intended for short-term use. Esmolol hydrochloride is indicated for the short-term treatment of tachycardia and/or hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia and in the postoperative period, when in the physician’s judgment such specific intervention is considered indicated. Use of esmolol hydrochloride to prevent such events is not recommended. Esmolol hydrochloride is contraindicated in patients with: Pregnancy Category C. Esmolol hydrochloride has been shown to produce increa

Product summary:

Esmolol Hydrochloride Injection Available overbagged in 100 mg / 10 mL (10 mg/mL) Ready-to-use Vials, with 1vial per bag, NDC 55154-2888-8. Store at 25˚C (77˚F). Excursions permitted to 15˚-30˚C (59˚-86˚F) [see USP Controlled Room Temperature]. Protect from freezing. Avoid excessive heat.

Authorization status:

New Drug Application

Summary of Product characteristics

                                ESMOLOL HYDROCHLORIDE- ESMOLOL HYDROCHLORIDE INJECTION
CARDINAL HEALTH
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
ESMOLOL HYDROCHLORIDE SAFELY AND
EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ESMOLOL
HYDROCHLORIDE INJECTION.
ESMOLOL HYDROCHLORIDE INJECTION, FOR INTRAVENOUS USE
INITIAL U.S. APPROVAL: 1986
INDICATIONS AND USAGE
Esmolol hydrochloride injection is a beta adrenergic blocker indicated
for the short-term treatment of:
•
•
DOSAGE AND ADMINISTRATION
•
•
•
•
DOSAGE FORMS AND STRENGTHS
•
CONTRAINDICATIONS
•
•
•
•
•
•
•
•
WARNINGS AND PRECAUTIONS
•
•
•
•
•
ADVERSE REACTIONS
Control of ventricular rate in supraventricular tachycardia including
atrial fibrillation and atrial flutter and control of
heart rate in noncompensatory sinus tachycardia (1.1)
Control of perioperative tachycardia and hypertension (1.2)
Administer intravenously (2.1, 2.2)
Titrate using ventricular rate or blood pressure at ≥4-minute
intervals. (2.1, 2.2)
Supraventricular tachycardia (SVT) or noncompensatory sinus
tachycardia (2.1)
7.
8.
9.
10.
Optional loading dose: 500 mcg per kg infused over one minute
Then 50 mcg per kg per minute for the next 4 minutes
Adjust dose as needed to a maximum of 200 mcg per kg per minute.
Additional loading doses may be administered
Perioperative tachycardia and hypertension (2.2)
11.
12.
Loading dose: 500 mcg per kg over 1 minute for gradual control (1 mg
per kg over 30 seconds for immediate
control)
Then 50 mcg per kg per min for gradual control (150 mcg per kg per
minute for immediate control) adjusted to a
maximum of 200 (tachycardia) or 300 (hypertension) mcg per kg per min
(2.2)
Injection: 100 mg/10 mL (10 mg/mL) in 10 mL vial (3)
Severe sinus bradycardia (4)
Heart block greater than first degree (4)
Sick sinus syndrome (4)
Decompensated heart failure (4)
Cardiogenic shock (4)
Coadministration of IV cardiodepressant calcium-channel antagonists
(e.g. verapamil) in close proximity to e
                                
                                Read the complete document
                                
                            

Search alerts related to this product